Novartis AG

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 57037.87, 60068.75, 63588.79 ], "ebit_estimate": [ 20199.11, 21590.16, 23510.07 ], "ebitda_estimate": [ 23553.74, 25095.87, 26952.33 ], "net_income_estimate": [ 16753.59, 18106.69, 19998.93 ], "per_share_eps_estimate": [ 7.26, 8.02, 8.89 ], "eps_nri_estimate": [ 8.87, 9.75, 10.64 ], "dividend_estimate": [ 4.45, 4.63, 4.8 ], "book_value_per_share_estimate": [ 25.31, 27.12, 31.65 ], "pretax_income_estimate": [ 18654.01, 20325.82, 22790.94 ], "operating_cash_flow_per_share_estimate": [ 9.78, 10.66, 11.93 ], "roa_estimate": [ 13.63, 14.18, 15.13 ], "roe_estimate": [ 34.34, 34.9, 34.47 ], "gross_margin_estimate": [ 79.13, 79.13, 79.86 ], "operating_cash_flow_estimate": [ 18948.32, 20643.19, 23113.45 ], "pettm_estimate": [ 21.05, 19.07, 17.19 ], "long_term_growth_rate_mean": 12.57, "long_term_revenue_growth_rate_mean": "3.94", "future_per_share_eps_estimate_growth": 8.86, "future_eps_nri_estimate_growth": 12.57, "future_revenue_estimate_growth": 3.94, "future_ebit_estimate_growth": 10.12, "future_ebitda_estimate_growth": 5.73, "future_dividend_estimate_growth": 7.74, "future_net_income_estimate_growth": 11.34, "future_pretax_income_estimate_growth": 11.4, "future_book_value_per_share_estimate_growth": 7.86, "future_roa_estimate_growth": 7.69, "future_roe_estimate_growth": 6.8, "future_gross_margin_estimate_growth": 1.83, "future_operating_cash_flow_per_share_estimate_growth": 4.55 }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709" ], "revenue_estimate": [ 13356.98, 13786.49, 14158.2, 14493.15, 13820, 14400, 14635 ], "ebit_estimate": [ 4753.64, 4806.36, 4827.89, 4680.69, null, null, null ], "ebitda_estimate": [ 4142.28, 4392.71, 4315.77, 4792.37, null, null, null ], "net_income_estimate": [ 4133.12, 4109.45, 4139.16, 3949.08, null, null, null ], "per_share_eps_estimate": [ 1.65, 1.72, 1.66, 1.85, null, null, null ], "eps_nri_estimate": [ 2.08, 2.17, 2.21, 2.28, 2.25, 2.37, 2.41 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 4740, 4980, 5100, 5045, 4985, 5205, 5245 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 82.7, 83, 83, 83.1, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 22.22, null, null, null, null, null, null ], "long_term_growth_rate_mean": 12.57, "long_term_revenue_growth_rate_mean": "3.94", "future_per_share_eps_estimate_growth": 8.86, "future_eps_nri_estimate_growth": 12.57, "future_revenue_estimate_growth": 3.94, "future_ebit_estimate_growth": 10.12, "future_ebitda_estimate_growth": 5.73, "future_dividend_estimate_growth": 7.74, "future_net_income_estimate_growth": 11.34, "future_pretax_income_estimate_growth": 11.4, "future_book_value_per_share_estimate_growth": 7.86, "future_roa_estimate_growth": 7.69, "future_roe_estimate_growth": 6.8, "future_gross_margin_estimate_growth": 1.83, "future_operating_cash_flow_per_share_estimate_growth": 4.55 }